IP Library Granted Patent US 8,146,603
Granted Patent B2
US 8,146,603 · App. 13/092,747 · Granted Apr 3, 2012

Method for ablating body tissue

View Patent ↗
Loading inventors, assignments & file history…
Monitor This Case
Get email alerts when status or documents change.
Order Certified Copies
Most orders are placed with the USPTO same day — all within 24 business hours.
Order via The Patent Place →
Pre-filled with this patent's details
Quick Facts
Patent No.
US 8,146,603
App. No.
13/092,747
Granted
Apr 3, 2012
Kind
B2
Abstract

A tissue ablation system for treating fibrillation in a patient comprises a steerable interventional catheter having an energy source that emits a beam of energy to ablate tissue thereby creating a conduction block for aberrant electrical pathways. The system also includes a handle disposed near a proximal end of the interventional catheter and has an actuation mechanism for steering the interventional catheter. A console allows the system to be controlled and provides power to the system, and a display pod is electrically coupled with the console. The display pod has a display panel to display system information to a user and allows the user to control the system. A catheter pod is releasably coupled with the handle electrically and mechanically, and also electrically coupled with the display pod.

Claims (30)

1. A method for ablating cardiac tissue, said method comprising:

advancing a treatment catheter through a patient's vasculature into an atrium of a heart, the treatment catheter comprising an ultrasound emitter disposed near a distal end thereof;

positioning the ultrasound emitter to face heart tissue within the left atrium and outside of a pulmonary vein;

ablating the heart tissue with ultrasound energy from the ultrasound emitter to form a first lesion outside of a pulmonary vein while rotating the ultrasound emitter about a first rotation axis, wherein the first lesion encircles the ostia of the pulmonary vein,

wherein the first lesion is formed without direct contact between the ultrasound emitter and the heart tissue, and wherein the ablating step is performed with the ultrasound energy being directed distally from a distally facing surface of the ultrasound emitter, and

wherein the ultrasound energy is initially directed at an inner wall of the heart;

sensing a gap distance with a sensor coupled to the treatment catheter, the gap distance extending between the ultrasound emitter and the heart tissue;

based on the sensed gap distance, controlling re-positioning of the ultrasound emitter position by adjusting the gap distance between the ultrasound emitter and the heart tissue while maintaining the gap therebetween within an ablation window length, wherein adjusting comprises proximal or distal axial movement of the ultrasound emitter relative to the heart tissue;

cooling the ultrasound emitter with fluid wherein the fluid flows past the ultrasound emitter and exits the treatment catheter; and

providing a separation between the ultrasound emitter and blood in the atrium to prevent the blood from coagulating on the ultrasound emitter, wherein the separation comprises the fluid.

2. The method of claim 1 , wherein the ultrasound energy from the ultrasound emitter comprises a collimated beam.

3. The method of claim 1 , wherein the ultrasound emitter comprises an ultrasound transducer, and wherein the sensor comprises the ultrasound transducer.

4. The method of claim 1 , wherein the positioning comprises bending a distal portion of the treatment catheter.

5. The method of claim 1 , further comprising anchoring the treatment catheter.

6. The method of claim 5 , wherein anchoring the treatment catheter comprises placing an anchor against a wall of the atrium.

7. The method of claim 5 , wherein anchoring the treatment catheter comprises placing an anchor within a pulmonary vein.

8. The method of claim 5 , wherein anchoring the treatment catheter comprises expanding an anchor.

9. The method of claim 1 , wherein positioning comprises rotating the treatment catheter.

10. The method of claim 1 , further comprising sensing depth of ablation in the heart tissue and adjusting the ultrasound energy.

11. The method of claim 10 , wherein the ultrasound emitter comprises an ultrasound transducer and sensing the depth of ablation comprises sensing the depth of ablation with the ultrasound transducer.

12. The method of claim 1 , further comprising:

ablating the heart tissue with ultrasound energy from the ultrasound emitter to form a second lesion outside of a second pulmonary vein while rotating the ultrasound emitter about a second rotation axis, wherein the second lesion encircles the ostia of the second pulmonary vein,

wherein the second lesion is formed without direct contact between the ultrasound emitter and the heart tissue, and wherein ablating the second pulmonary vein is performed with the ultrasound energy being directed distally from a distally facing surface of the ultrasound emitter, and

wherein the ultrasound energy is initially directed at an inner wall of the heart.

13. The method of claim 12 , further comprising ablating the heart tissue with the ultrasound energy to form a connecting lesion while moving the ultrasound emitter between the first lesion and the second lesion, wherein the connecting lesion crosses the first and the second lesions.

14. The method of claim 13 , further comprising ablating the heart tissue with the ultrasound energy to form a transverse lesion while moving the ultrasound emitter between the connecting lesion and the mitral valve, wherein the transverse lesion crosses the connecting lesion and extends toward the mitral valve.

15. The method of claim 1 , further comprising controlling lesion depth by adjusting distance between the ultrasound emitter and the heart tissue with proximal or distal axial movement of the ultrasound emitter relative to the heart tissue.

16. The method of claim 1 , further comprising controlling lesion depth by adjusting the ultrasound energy.

17. The method of claim 1 , further comprising sensing heart tissue thickness and controlling depth of the first lesion by adjusting distance between the ultrasound emitter and the heart tissue with proximal or distal axial movement of the ultrasound emitter relative to the heart tissue.

18. The method of claim 1 , further comprising sensing thickness of the heart tissue and controlling depth of the first lesion by adjusting the ultrasound energy.

Assignments (6)
ASSIGNMENT OF ASSIGNOR'S INTEREST Recorded Jun 4, 2020
From: VYTRONUS, INC.
To: AURIS HEALTH, INC.
Reel/Frame 052845/0078 →
RELEASE OF SECURITY INTEREST Recorded Dec 27, 2019
From: SILICON VALLEY BANK
To: VYTRONUS, INC.
Reel/Frame 051435/0001 →
SECURITY INTEREST Recorded Nov 27, 2019
From: VYTRONUS, INC.
To: SILICON VALLEY BANK
Reel/Frame 051147/0163 →
ASSIGNMENT OF ASSIGNOR'S INTEREST Recorded Sep 10, 2014
From: VYTRONUS, INC.
To: HANTEL TECHNOLOGIES, INC.
Reel/Frame 033713/0166 →
CORRECTIVE ASSIGNMENT TO CORRECT THE CONVEYING/RECEIVING PARTIES TRANSPOSED PREVIOUSLY RECORDED AT REEL: 033713 FRAME: 0166. ASSIGNOR(S) HEREBY CONFIRMS THE ASSIGNMENT. Recorded Sep 10, 2014
From: HANTEL TECHNOLOGIES, INC.
To: VYTRONUS, INC.
Reel/Frame 033763/0046 →
ASSIGNMENT OF ASSIGNOR'S INTEREST Recorded Apr 1, 2014
From: THAPLIYAL, HIRA V.; GALLUP, DAVID A.; ARENSON, JAMES W.
To: VYTRONUS, INC.
Reel/Frame 032572/0773 →